JP Stock MarketDetailed Quotes

4893 Noile-Immune Biotech

Watchlist

145
+2+1.40%

20min DelayTrading May 13 09:09 JST

6.28BMarket Cap-6.51P/E (Static)

Noile-Immune Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Noile-Immune Biotech Q1 2025 Earnings Date

Currency：JPYMay 12, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	2.00M	--
		-22.69%
EPS	--	-5.55	--
		+29.40%

Analyst Rating

Strong Buy

Dec 19, 2023

Noile-Immune Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
May 12, 2025	2025/Q1	2.000M / --	--
Nov 14, 2024	2024/Q3	3.000M / --	--
May 14, 2024	2024/Q1	2.000M / --	--
Nov 13, 2023	2023/Q3	303.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

May 12, 20252025/Q12.000M / ----

Nov 14, 20242024/Q33.000M / ----

May 14, 20242024/Q12.000M / ----

Nov 13, 20232023/Q3303.000M / ----

--------

Unlock Free Earnings Estimates

Open Account

Noile-Immune Biotech Earnings Reports

Noile-Immune Biotech: Summary of financial results for the 1st quarter of the fiscal year ending 2025/12 [Japanese GAAP] (unconsolidated)

May 12 03:30 ET

Noile-Immune Biotech: Extraordinary Report

Apr 1 03:11 ET

Noile-Immune Biotech: Confirmation letter

Mar 28 00:44 ET

Noile-Immune Biotech: Financial Report - 10th Term (2024/01/01 - 2024/12/31)

Mar 28 00:42 ET